Boswellic acids in chronic inflammatory diseases

被引:243
作者
Ammon, H. P. T. [1 ]
机构
[1] Univ Tubingen, Dept Pharmacol, Inst Pharmaceut Sci, D-72076 Tubingen, Germany
关键词
boswellic acids; anti-inflammatory actions; immune system; leukotrienes; chronic bowel diseases; arthritis; bronchial asthma;
D O I
10.1055/s-2006-947227
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Oleogum resins from Boswellia species are used in traditional medicine in India and African countries for the treatment of a variety of diseases. Animal experiments showed anti-inflammatory activity of the extract. The mechanism of this action is due to some boswellic acids. It is different from that of NSAID and is related to components of the immune system. The most evident action is the inhibition of 5-lipoxygenase. However, other factors such as cytokines (interleukins and TNF-alpha) and the complement system are also candidates. Moreover, leukocyte elastase and oxygen radicals are targets. Clinical studies, so far with pilot character, suggest efficacy in some autoimmune diseases including rheumatoid arthritis, Crohn's disease, ulcerative colitis and bronchial asthma. Side effects are not severe when compared to modern drugs used for the treatment of these diseases.
引用
收藏
页码:1100 / 1116
页数:17
相关论文
共 72 条
[1]
Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes [J].
Altmann, A ;
Poeckel, D ;
Fischer, L ;
Schubert-Zsilavecz, M ;
Steinhilber, D ;
Werz, O .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (02) :223-232
[2]
Boswellic acids activate p42MAPK and p38 MAPK and stimulate Ca2+ mobilization [J].
Altmann, A ;
Fischer, L ;
Schubert-Zsilavecz, M ;
Steinhilber, D ;
Werz, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (01) :185-190
[3]
AMMON HPT, 1993, J ETHNOPHARMACOL, V38, P113, DOI 10.1016/0378-8741(93)90005-P
[4]
INHIBITION OF LEUKOTRIENE-B4 FORMATION IN RAT PERITONEAL NEUTROPHILS BY AN ETHANOLIC EXTRACT OF THE GUM RESIN EXUDATE OF BOSWELLIA-SERRATA [J].
AMMON, HPT ;
MACK, T ;
SINGH, GB ;
SAFAYHI, H .
PLANTA MEDICA, 1991, 57 (03) :203-207
[5]
Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis [J].
Anthoni, C. ;
Laukoetter, M. G. ;
Rijcken, E. ;
Vowinkel, T. ;
Mennigen, R. ;
Mueller, S. ;
Senninger, N. ;
Russell, J. ;
Jauch, J. ;
Bergmann, J. ;
Granger, D. N. ;
Krieglstein, C. F. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (06) :G1131-G1137
[6]
Badria FA, 2003, Z NATURFORSCH C, V58, P505
[7]
Basch Ethan, 2004, Journal of Herbal Pharmacotherapy, V4, P63, DOI 10.1080/J157v04n03_06
[8]
Beisner K, 2003, MAGN RESON CHEM, V41, P629
[9]
MEK-1/2 inhibition prevents 5-lipoxygenase translocation in N-formylpeptide-challenged human neutrophils [J].
Boden, SE ;
Bertsche, T ;
Ammon, HPT ;
Safayhi, H .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (10) :1069-1074
[10]
Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid [J].
Boden, SE ;
Schweizer, S ;
Bertsche, T ;
Düfer, M ;
Drews, G ;
Safayhi, H .
MOLECULAR PHARMACOLOGY, 2001, 60 (02) :267-273